在脂质纳米粒子中使用新型辅助剂的化学,制造和控制策略
Matthew O'Brien Laramy1, David A Foley2, Roger H Pak3
1Synthetic Molecule Pharmaceutical Sciences, Genentech Early Research and Development, Genentech, Inc., South San Francisco, CA, USA. obrienlm@gene.com.
Nature nanotechnology
|January 17, 2025
概括
脂质纳米颗粒 (LNP) 中的新型脂质面临严格的监管障碍,推迟了创新. 解决化学,制造和控制方面的挑战可以简化LNP开发和监管途径.
科学领域:
- 制药科学 制药科学
- 生物技术是生物技术.
- 药物输送系统 药物输送系统
背景情况:
- 脂质纳米颗粒 (LNP) 使用新型脂质作为功能辅助物来优化核酸输送.
- 这些新型辅助剂受到严格的监管审查,类似于药品活性成分.
- 这种加强的审查对LNP创新和临床开发构成了重大经济和程序障碍.
研究的目的:
- 为行业提供一个关于与LNP中新型脂质辅助剂相关的挑战的视角.
- 概述制药公司在LNP开发过程中面临的化学,制造和控制 (CMC) 挑战.
- 提出共识性建议,以简化LNP的开发和监管期望.
主要方法:
- 基于行业的观点和对当前监管环境的分析.
- 对新型脂类辅助剂的化学,制造和控制 (CMC) 考虑的审查.
- 在LNP产品开发的各个阶段识别挑战.
主要成果:
- 在LNP中的新型脂质辅助剂面临着重大的监管负担,影响开发时间表和成本.
- 由于缺乏针对LNP中的脂质辅助剂的具体全球监管指导,造成了不确定性.
- 当前的监管要求,在确保安全的同时,可能会阻碍创新和临床进步.
结论:
- 对新型脂质辅助剂的监管期望进行协调对于推进LNP技术至关重要.
- 简化CMC开发和监管审查可以加速LNP的临床研究.
- 需要行业和监管机构之间的协作努力,以便为LNP发展制定明确的指导方针.
更多相关视频
13:54A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
Published on: August 18, 2023
4.4K
11:27A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
Published on: August 9, 2022
2.0K
相关概念视频
Factors Influencing Drug Absorption: Pharmaceutical Parameters
113
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
113
Factors Affecting Dissolution: Particle Size and Effective Surface Area
708
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
708
